ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print January 22, 2009
Eur Respir J 2009, doi:10.1183/09031936.00116808
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
33/5/1025    most recent
09031936.00116808v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weatherall, M.
Right arrow Articles by Beasley, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weatherall, M.
Right arrow Articles by Beasley, R.


ORIGINAL ARTICLE

Quality of life measured by the St George's Respiratory Questionnaire and spirometry

M. Weatherall 1, S. Marsh 2, P. Shirtcliffe 2, M. Williams 2, J. Travers 2, R. Beasley 2*

1 University of Otago Wellington, Wellington, New Zealand
2 Medical Research Institute of New Zealand, Wellington, New Zealand

* To whom correspondence should be addressed. E-mail: Richard.Beasley{at}mrinz.ac.nz.


   Abstract

We aimed to determine if the criteria for the diagnosis of COPD and its classification by severity as recommended by the Global Initiative for Obstructive Lung Disease are supported by measurements of respiratory health-related quality of life.

A community-based sample of adults aged 25 to 75 years had pre- and post-bronchodilator spirometry and completed the St George's Respiratory Questionnaire (SGRQ). Loess scatter plot smoothers of SGRQ versus post-bronchodilator FEV1/FVC ratio and post-bronchodilator FEV1 as percent predicted together with receiver operating characteristic (ROC) curve analysis were used to determine the relationship between spirometric variables and clinically important differences in the SGRQ score.

The scatter plot smoother and ROC curve analyses supported the value of 0.7 for post-bronchodilator FEV1/FVC, which was about four units higher than the nadir of the SGRQ. To represent a distance of eight units on SGRQ, the cut-points for post-bronchodilator FEV1 that delimit COPD severity stages were 80%, 60% and 40% predicted.

To diagnose COPD the use of a post-bronchodilator FEV1/FVC of 0.7 is supported by health-related quality of life measurements. There may be advantages in using FEV1 cut-points of 80%, 60% and 40% predicted for the classification of mild, moderate and severe COPD, similar to the approach recommended for asthma.

Keywords:  COPD, quality of life, spirometry







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the European Respiratory Society.